Transcript Document

First HAYAT Annual Patients Forum
21st March 2010
Al Hashimi II Ballroom – SAS Hotel
Kuwait
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
Access to medicine is essential for better outcome
Dr. Jaroslav Nemec
Consultant Medical Oncologist
Head of GI Unit, Medical Oncology Department - KCCC
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
Cancer Therapy
• Many cancer patients require surgery and
radiotherapy and medical therapy
• All medicines we use have been scientifically
proven to be effective and beneficial
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
Cancer Therapy
• All anticancerous medicines are expensive
• Prices ranging from dozens to thousands KD
monthly
• Some patients may require medicines for years
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
Cancer Therapy
• Medicines may cure some cancers, or extend
the life of incurable patients
• Access to medicines is critical for cure or
extending the lives
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
Cancer Therapy
• Almost all cancer medicines in Kuwait are
granted for all patients
• Only few expensive medicines may not be
provided for non-Kuwaiti patients
• HERE THE HAYAT FUND COMES
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
SHARING DOCTOR’S
THOUGHTS
HOW TO USE THE HAYAT SUPPORT
FOR THE BEST BENEFIT OF OUR
PATIENTS
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
SHARING DOCTOR’S
THOUGHTS
• All medicines we use have been rigorously
tested to be proven beneficial
• More expensive not always means more
beneficial
• Some expensive medicines save lives, some
add little
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
MEDICAL ONCOLOGY
DEPARTMENT POLICY
• Selecting the patients who would benefit
most
• Selecting the medicines wisely = those
providing most of the benefit
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
MEDICAL ONCOLOGY
DEPARTMENT POLICY
HAYAT
Supports several expensive drugs used at
the Medical Oncology Department
for different cancers
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
BREAST CANCER
• Class: Molecular targeted agents
• Used for a specific type of breast cancer, specially tested
for benefit from the drugs
• Injections and tablets
• Cost: 1000-1500 KD monthly. Many patients would be
on treatment for more than a year, even few years.
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
BREAST CANCER
• Benefit from the drugs:
• After operation, the risk of cancer returning is reduced
• In advanced breast cancer, these drugs improve benefit
from chemotherapy and hormonal therapy (more
patients would experience tumor shrinkage and live
longer) and reduces symptoms induced by the disease
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
BREAST CANCER
• Class: Hormonal therapy
• Used for a specific type of breast cancer, specially tested
for benefit from the drugs
• Tablets
• Cost: 95 KD/month, 1140 KD/year. Many patients would
be on treatment for more than a year, even few years.
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
BREAST CANCER
• Benefit from the drug:
• After operation, the risk of cancer returning is
reduced
• In advanced breast cancer, the drug prolongs
the life and reduces symptoms induced by the
disease
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
NON-HODGKIN’S LYMPHOMA
• Class: monoclonal antibody
• Used in some specific types of non-Hodgkin’s
lymphoma, in combination with chemotherapy or
alone
• Cost: One dose = about 800 KD, total cost
varies according to the schedule, may exceed
7,000 KD
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
NON-HODGKIN’S LYMPHOMA
• Benefit from the drug:
• More patients would be cured with
chemotherapy
• In patients who can’t be cured, the drug
prolongs the life and reduces symptoms induced
by the disease
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
MEDICINES SUPPORTED BY HAYAT
FUND USED IN DIFFERENT CANCERS
1) The drug controlling vessels supplying the tumor with
blood
• Effective in colon, lung, ovarian, breast, brain cancers.
• Cost: May differ in different cancers. Around 1300
KD/months, 4000 KD/3 months
• Benefit: Improves benefit from chemotherapy, prolongs
life in some cancers, reduces problems from disease
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
MEDICINES SUPPORTED BY HAYAT
FUND USED IN DIFFERENT CANCERS
2) The drugs used in lung, pancreatic, liver, kidney cancers and rare
diseases of digestive tract:
• Different classes of drugs
• Don’t cure the disease
• May prolong life, prolong time the tumor is not growing, control
symptoms of cancer
• Cost: Very different. 1000 – 2000 KD/month, used for several
months, some for several years.
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
SUPPORT FROM HAYAT FUND IS
CRITICAL FOR MANY OF OUR
PATIENTS
USING THE SUPPORT WISELY AND
EFFECTIVELY IS DOCTORS’
CONTRIBUTION
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait
Thank You
Dr. Jaroslav Nemec
Consultant Medical Oncologist
Head of GI Unit, Medical Oncology Department - KCCC
First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait